Jan F Keij

Title: Jan F Keij: Innovator in Photoinactivation of Malignant Cells

Introduction

Jan F Keij is a notable inventor based in Los Alamos, NM (US). She has made significant contributions to the field of medical technology, particularly in the area of cancer treatment. Her innovative approach focuses on the photoinactivation of malignant cells, which has the potential to improve therapeutic outcomes for patients.

Latest Patents

Jan F Keij holds a patent for a method titled "Method for Photoinactivating Malignant Cells." This invention provides a technique for photoinactivating malignant cells in a cell sample. The method involves incubating the cell sample with a concentration of Pc 4 that effectively causes a substantial number of malignant cells to absorb Pc 4. Upon application of a sufficient dose of red light, the absorbed malignant cells are photoinactivated. This innovative approach could lead to advancements in cancer treatment methodologies.

Career Highlights

Jan F Keij is currently associated with the New York Blood Center, Inc., where she continues her research and development efforts. Her work is pivotal in exploring new methods for treating cancer, showcasing her dedication to improving patient care through innovative solutions.

Collaborations

Jan F Keij has collaborated with esteemed colleagues such as Ehud Ben-Hur and Robert A Preti. These collaborations have further enriched her research and contributed to the advancement of her patented methods.

Conclusion

Jan F Keij is a pioneering inventor whose work in photoinactivation of malignant cells represents a significant advancement in cancer treatment. Her innovative methods and collaborations highlight her commitment to improving healthcare outcomes.